These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9548596)

  • 1. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts.
    Honda M; Tint GS; Honda A; Nguyen LB; Chen TS; Shefer S
    J Lipid Res; 1998 Mar; 39(3):647-57. PubMed ID: 9548596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
    Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
    J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome.
    Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N
    J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome.
    Honda A; Tint GS; Salen G; Kelley RI; Honda M; Batta AK; Chen TS; Shefer S
    Am J Med Genet; 1997 Jan; 68(3):282-7. PubMed ID: 9024560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts.
    Shefer S; Salen G; Honda A; Batta A; Hauser S; Tint GS; Honda M; Chen T; Holick MF; Nguyen LB
    Metabolism; 1997 Jul; 46(7):844-50. PubMed ID: 9225842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome: rapid determination of plasma 7-dehydrocholesterol by ultraviolet spectrometry.
    Honda A; Batta AK; Salen G; Tint GS; Chen TS; Shefer S
    Am J Med Genet; 1997 Jan; 68(3):288-93. PubMed ID: 9024561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
    Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
    J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
    Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS
    Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
    Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
    Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
    J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
    Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
    J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
    Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
    Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome.
    Weinhofer I; Kunze M; Stangl H; Porter FD; Berger J
    Biochem Biophys Res Commun; 2006 Jun; 345(1):205-9. PubMed ID: 16678134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes.
    Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S
    J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome].
    Koczok K; V Oláh A; P Szabó G; Oláh É; Török O; Balogh I
    Orv Hetil; 2015 Oct; 156(42):1695-702. PubMed ID: 26551309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
    Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
    Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
    Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A
    J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
    Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
    J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
    Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
    J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
    Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
    Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.